Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Body aches and pains; Chest pain within 48 hours. A 5/10 on pain. Tightness; raised warm welt at injection site within 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches and pains), CHEST PAIN (Chest pain within 48 hours. A 5/10 on pain. Tightness) and VACCINATION SITE URTICARIA (raised warm welt at injection site within 24 hours) in a 24-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 31-Jul-2025, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On 01-Aug-2025, the patient experienced PAIN (Body aches and pains), CHEST PAIN (Chest pain within 48 hours. A 5/10 on pain. Tightness) and VACCINATION SITE URTICARIA (raised warm welt at injection site within 24 hours). At the time of the report, PAIN (Body aches and pains), CHEST PAIN (Chest pain within 48 hours. A 5/10 on pain. Tightness) and VACCINATION SITE URTICARIA (raised warm welt at injection site within 24 hours) had not resolved. The action taken with mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) was unknown. Concomitant medication was not reported. Patient had body aches and pains, raised warm welt at injection site within 24 hours, chest pain within 48 hours, A 5/10 on pain, and tightness. It was unknown if she experienced any additional symptoms/events. The patient had no medical history, concomitant disease, or risk factor. There were no lab data/results available. Treatment medication was not reported.